Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 582 (MIR582) is a human non-coding RNA gene that produces two mature microRNAs: hsa-miR-582-5p and hsa-miR-582-3p[1][2]. These small regulatory RNAs play post-transcriptional roles in gene silencing, impacting mRNA stability and translation[3]. MIR582 is implicated in multiple biological functions including regulation of cell proliferation, apoptosis, and maintenance of stemness in both cancer stem cells and neural stem cells[1][3]. In cancer, miR-582-5p and miR-582-3p have been shown to both suppress and promote tumor progression depending on the context, for example, by targeting oncogenic pathways (including NOTCH1 and Hippo-YAP/TAZ) or enhancing epithelial-mesenchymal transition (EMT)[1][4][5][6][7]. The molecule serves as a biomarker for tumorigenicity and may represent a novel therapeutic target, though no approved drugs directly target MIR582 to date. Safety concerns involve the broad regulatory functions of microRNAs, raising issues for off-target effects and the impact on normal stem cell function[3].
Regulates gene expression by binding to target mRNAs, leading to mRNA degradation or repression of translation\n- Suppression of oncogenic pathways (e.g., Hippo-YAP/TAZ, NOTCH1)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 582 (MIR582).